Kwmg, LLC Gilead Sciences, Inc. Transaction History

Kwmg, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$61.87 - $69.38 $2,846 - $3,191	-46 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $13,193 - $14,780	-211 Reduced 82.1%	46 $3,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $3,995 - $5,214	-66 Reduced 20.43%	257 $16,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $7,555 - $8,365	-106 Reduced 24.71%	323 $25,000
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $1.35 Million - $1.57 Million	-20,768 Reduced 97.98%	429 $30,000
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $379,787 - $463,003	-5,214 Reduced 19.74%	21,197 $1.6 Million
Q4 2017 Jan 26, 2018	BUY	$71.15 - $83.52 $101,815 - $119,517	1,431 Added 5.73%	26,411 $1.89 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.8 Million - $2.14 Million	24,980	24,980 $2.02 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kwmg, LLC, based on Form 13F filings with the SEC.

Stay updated on Kwmg, LLC with notifications on news.